[ad_1]
The European Medicines Agency (EMA) evaluates an increasing number of new cancer medicines. EMA collaborates with the European medicines regulatory network and international regulators to address the unmet needs of cancer patients. This is meant to advance cancer care and alleviate the burden of cancer in the European Union (EU). It is in line with EMA’s role to foster scientific excellence in the evaluation and supervision of medicines.
[ad_2]
Source link
